Figure 2
Figure 2. MYH10 detection in platelets from CMML patients. (A) Immunoblot analysis of MYH10 expression in platelets from patients with CMML. HEL cells were used as positive controls, Co 1 platelets as negative control, and HSC70 as loading control. (B) Statistical evaluation of correlation between MYH10 presence in platelets of patients with CMML, RCMD, AML-M4, and reactive monocytosis and thrombopenia degree. MYH10+ indicates patients with the presence of MYH10 in platelets; and MYH10−, patients with the absence of MYH10 in platelets. **P < .007 (Mann-Whitney U test). Statistical analyses were carried out with Prism, Version 5.0 (Graphpad Software).

MYH10 detection in platelets from CMML patients. (A) Immunoblot analysis of MYH10 expression in platelets from patients with CMML. HEL cells were used as positive controls, Co 1 platelets as negative control, and HSC70 as loading control. (B) Statistical evaluation of correlation between MYH10 presence in platelets of patients with CMML, RCMD, AML-M4, and reactive monocytosis and thrombopenia degree. MYH10+ indicates patients with the presence of MYH10 in platelets; and MYH10−, patients with the absence of MYH10 in platelets. **P < .007 (Mann-Whitney U test). Statistical analyses were carried out with Prism, Version 5.0 (Graphpad Software).

Close Modal

or Create an Account

Close Modal
Close Modal